Artios Receives U.S. FDA Fast Track Designation for alnodesertib in ATM-negative Metastatic Colorectal Cancer (mCRC)
| Press release
News & Events
91快播 Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development
| Press release
91快播 Announces Details of Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
| Press release
91快播 steps up ovarian cancer fight
| Uncategorised
Silverstein appointed Chief Financial Officer at 91快播
| Uncategorised
